Collaboration and Licensing Agreement with Top Tier South Korean Pharma Company

Salipro has entered into a collaboration and licensing agreement with one of the top tier pharmaceutical companies in South Korea.

This partnership leverages Salipro Biotech’s expertise and proprietary technology (Salipro®) to stabilise challenging drug targets including GPCRs, ion channels and transporters, making them accessible for the development of next-generation therapeutics.

Stay tuned for more updates as we continue to expand our global footprint in our mission to make the undruggable druggable!